Forest flunisolide HFA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA deems the hydrofluoralkane-formulated, non-CFC version of Forest's asthma treatment Aerobid "approvable" May 7. The approvable letter requests additional data, which the firm is preparing. Forest anticipates product launch in late 2001 or in 2002